Sign in
4

Changes in Ownership

Travere Therapeutics, Inc. Filed Acc 0001415889-25-002001

CHIEF COMMERCIAL OFFICER sold 1,584 shares at $18.94 ($30,002)

From the SEC's structured data for this filing

Trades in this filing

Heerma Peter · CHIEF COMMERCIAL OFFICER

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-01-22 Sale : show line 1 in the form −1,584 $18.94 $30,002 106,374 D
Open-market sales · 1,584 sh · avg $18.94 · $30,002
Loading xslF345X05/form4-01242025_010141.xml…